Trials / Available
AvailableNCT04959240
Expanded Access to Velmanase Alfa
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Chiesi Farmaceutici S.p.A. · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
Individual patient expanded access requests may be considered for patients who have no other treatment options.
Detailed description
Expanded access may provide access for treatment prior to approval by the local regulatory agency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Velmanase Alfa |
Timeline
- First posted
- 2021-07-13
- Last updated
- 2023-09-25
Source: ClinicalTrials.gov record NCT04959240. Inclusion in this directory is not an endorsement.